ATE99954T1 - Verwendung bestimmter gamma-interferone zur behandlung von krebs des ovars. - Google Patents

Verwendung bestimmter gamma-interferone zur behandlung von krebs des ovars.

Info

Publication number: ATE99954T1
Authority: AT; Austria
Prior art keywords: cancer; treatment; ovary; gamma interferons; certain gamma
Prior art date: 1989-02-02

Application number

AT90400266T

Other languages

English (en)

Inventor

Maud Brandely

Danielle Lando

Original Assignee

Roussel Uclaf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-02

Filing date

1990-02-01

Publication date

1994-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9378406&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE99954(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-02-01 Application filed by Roussel Uclaf filed Critical Roussel Uclaf

1994-01-15 Application granted granted Critical

1994-01-15 Publication of ATE99954T1 publication Critical patent/ATE99954T1/de

Links

206010033128 Ovarian cancer Diseases 0.000 title abstract 2
206010061535 Ovarian neoplasm Diseases 0.000 title abstract 2
102000014150 Interferons Human genes 0.000 title 1
108010050904 Interferons Proteins 0.000 title 1
229940047124 interferons Drugs 0.000 title 1
102000008070 Interferon-gamma Human genes 0.000 abstract 1
108010074328 Interferon-gamma Proteins 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229940044627 gamma-interferon Drugs 0.000 abstract 1
230000010412 perfusion Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT90400266T 1989-02-02 1990-02-01 Verwendung bestimmter gamma-interferone zur behandlung von krebs des ovars. ATE99954T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8901346A FR2644067B1 (fr)	1989-02-02	1989-02-02	Utilisation de certains interferons gamma pour la preparation de compositions pharmaceutiques destinees au traitement du cancer de l'ovaire par voie intraperitoneale

Publications (1)

Publication Number	Publication Date
ATE99954T1 true ATE99954T1 (de)	1994-01-15

Family

ID=9378406

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90400266T ATE99954T1 (de)	1989-02-02	1990-02-01	Verwendung bestimmter gamma-interferone zur behandlung von krebs des ovars.

Country Status (12)

Country	Link
EP (1)	EP0381584B1 (de)
JP (1)	JPH0772137B2 (de)
KR (1)	KR100203316B1 (de)
AT (1)	ATE99954T1 (de)
AU (1)	AU632528B2 (de)
CA (1)	CA2009106A1 (de)
DE (1)	DE69005837T2 (de)
DK (1)	DK0381584T3 (de)
FR (1)	FR2644067B1 (de)
HU (1)	HU204711B (de)
OA (1)	OA09191A (de)
ZA (1)	ZA90671B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL76591A0 (en) *	1984-10-05	1986-02-28	Bioferon Biochem Substanz	Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
WO1987005518A1 (en) *	1986-03-17	1987-09-24	Schering Corporation	Treatment of cancers with gamma interferon

1989
- 1989-02-02 FR FR8901346A patent/FR2644067B1/fr not_active Expired - Fee Related
1990
- 1990-01-19 HU HU90202A patent/HU204711B/hu not_active IP Right Cessation
- 1990-01-24 JP JP2012778A patent/JPH0772137B2/ja not_active Expired - Lifetime
- 1990-01-30 ZA ZA90671A patent/ZA90671B/xx unknown
- 1990-02-01 AU AU48953/90A patent/AU632528B2/en not_active Expired
- 1990-02-01 DK DK90400266.4T patent/DK0381584T3/da active
- 1990-02-01 DE DE90400266T patent/DE69005837T2/de not_active Expired - Lifetime
- 1990-02-01 KR KR1019900001167A patent/KR100203316B1/ko not_active Expired - Lifetime
- 1990-02-01 EP EP90400266A patent/EP0381584B1/de not_active Expired - Lifetime
- 1990-02-01 AT AT90400266T patent/ATE99954T1/de not_active IP Right Cessation
- 1990-02-01 CA CA002009106A patent/CA2009106A1/fr not_active Abandoned
- 1990-02-02 OA OA59732A patent/OA09191A/xx unknown

Also Published As

Publication number	Publication date
HUT54302A (en)	1991-02-28
AU632528B2 (en)	1993-01-07
OA09191A (fr)	1992-06-30
DK0381584T3 (da)	1994-02-14
CA2009106A1 (fr)	1990-08-02
EP0381584A2 (de)	1990-08-08
FR2644067A1 (fr)	1990-09-14
KR100203316B1 (ko)	1999-06-15
EP0381584A3 (de)	1991-11-06
DE69005837T2 (de)	1994-05-11
JPH02235818A (ja)	1990-09-18
EP0381584B1 (de)	1994-01-12
HU900202D0 (en)	1990-03-28
FR2644067B1 (fr)	1993-02-05
DE69005837D1 (de)	1994-02-24
KR900012628A (ko)	1990-09-01
JPH0772137B2 (ja)	1995-08-02
AU4895390A (en)	1990-08-09
HU204711B (en)	1992-02-28
ZA90671B (en)	1991-04-24

Similar Documents

Publication	Publication Date	Title
DE69218956D1 (de)	1997-05-15	Förderung des hepatozytwachstums mit hepatozytwachstumsfaktor und gamma-interferon
DK53497A (da)	1997-05-09	Osteoinduktive præparater
ATE254926T1 (de)	2003-12-15	Verwendung eines consensus-interferons zur reduzierung der nebeneffekte in der interferon behandlung von viralen hepatiten.
ATE88900T1 (de)	1993-05-15	Konjugate von interferon alpha mit immunglobulinen.
DE68905438D1 (de)	1993-04-22	Verwendung von interferon-gamma in pharmazeutischen zubereitungen zur behandlung von gefaessstenose.
DE69007744D1 (de)	1994-05-05	Verwendung von Interleukin 2 zur Behandlung von Leukämien.
ATE74272T1 (de)	1992-04-15	Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie.
DE69431046D1 (de)	2002-08-29	Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen
DE69106407D1 (de)	1995-02-16	Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal.
DE68909267D1 (de)	1993-10-28	Medikament zur Behandlung von fibrotischer Störung und antifibrotische Verbindung.
DE3773295D1 (de)	1991-10-31	Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
ATE99954T1 (de)	1994-01-15	Verwendung bestimmter gamma-interferone zur behandlung von krebs des ovars.
DE3771584D1 (de)	1991-08-29	Zusammensetzungen und anwendung von interleukin-2 und/oder interferon-beta und des tumor-necrosis-faktors fuer eine kombinationstherapie oder zur herstellung von arzneimitteln oder formulierungen.
EP0180737A3 (en)	1986-05-28	Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
DE3869789D1 (de)	1992-05-14	Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
ATE100717T1 (de)	1994-02-15	Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons.
DE3484329D1 (de)	1991-05-02	Verwendung von gamma-interferon zur herstellung eines wirkstoffes in der behandlung von lepra.
DE3777224D1 (de)	1992-04-16	Verwendung von interferon-beta und interleukin-2 in der kombinationstherapie und zusammensetzungen dazu.
DK103891A (da)	1991-05-31	Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon
DE69004051D1 (de)	1993-11-25	Verwendung eines Polypeptides mit Gammainterferon-Aktivität zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von primitivem Pleura-Krebs.
ATE73346T1 (de)	1992-03-15	Verwendung von interferon-beta und interleukin-2 in der kombinationstherapie und zusammensetzungen dazu.
ATE88092T1 (de)	1993-04-15	Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten.

Legal Events

Date	Code	Title
1994-11-15	UEP	Publication of translation of european patent specification
2005-05-15	EEIH	Change in the person of patent owner
2010-05-15	EELA	Cancelled due to lapse of time